The UK Medicines and Healthcare products Regulatory Agency (MHRA) has published best practice guidance on patient information leaflets, covering two broad areas: the legal obligations that govern such documents and the principles of effective information design.
Legal Framework
According to the MHRA guidance, the regulatory requirements for patient information leaflets derive from both EU legislation and domestic national law. The guidance is intended to help those involved in producing or reviewing these materials understand and meet the applicable legal standards.
Information Design Standards
Beyond the legal requirements, the guidance also addresses best practice in information design as it applies specifically to patient information leaflets. This reflects a broader recognition that regulatory compliance alone does not guarantee that a leaflet will be accessible or useful to the people who rely on it.
The MHRA's dual focus — on legal compliance and on usability — suggests that the agency views the two as complementary rather than separate concerns when it comes to producing effective patient-facing documentation.